Cargando…

High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy

ATP-binding cassette (ABC) transporters are associated with poor response to chemotherapy, and confer a poor prognosis in various malignancies. However, the association between the expression of the ABC sub-family G member 4 (ABCG4) and prognosis in patients with non-small-cell lung cancer (NSCLC) r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Guang, Wang, Xue-Jiao, Huang, Li-Jun, Zhou, Yong-An, Tian, Feng, Zhao, Jin-Bo, Chen, Peng, Liu, Bo-Ya, Wen, Miao-Miao, Li, Xiao-Fei, Zhang, Zhi-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535915/ https://www.ncbi.nlm.nih.gov/pubmed/26270652 http://dx.doi.org/10.1371/journal.pone.0135576

Ejemplares similares

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy
por: Keck, Bastian, et al.
Publicado: (2013)

Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
por: Xu, Yu-Hua, et al.
Publicado: (2019)

miR-20b overexpression is predictive of poor prognosis in gastric cancer
por: Xue, Tong-min, et al.
Publicado: (2015)

Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2
por: Ke, Bin, et al.
Publicado: (2019)

High NEK2 confers to poor prognosis and contributes to cisplatin‐based chemotherapy resistance in nasopharyngeal carcinoma
por: Xu, He, et al.
Publicado: (2018)

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells
por: Guo, Jiwei, et al.
Publicado: (2018)

MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2
por: Wu, Yufeng, et al.
Publicado: (2020)

Concurrent chemotherapy using taxane plus cisplatin versus cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy
por: Zhang, Ya-Ni, et al.
Publicado: (2023)

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and Adjuvant Chemotherapy Resistance in Colorectal Cancer
por: Liu, Junyu, et al.
Publicado: (2023)

High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma
por: Shu, Hao, et al.
Publicado: (2021)

Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer
por: Jiang, Shu-Heng, et al.
Publicado: (2015)

Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma
por: Sun, Ying, et al.
Publicado: (2017)

High VCAM-1 Predicts Poor Prognosis and is Associated with Chemotherapy Resistance in Nasopharyngeal Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro
por: Guo, You-feng, et al.
Publicado: (2012)

Retraction notice to ‘The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells’ [EBioMedicine 35 (2018) 204–221]
por: Guo, Jiwei, et al.
Publicado: (2021)

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
por: Yang, Cuiping, et al.
Publicado: (2015)

Predictive role of Glutathione S-transferases (GSTs) on the prognosis of osteosarcoma patients treated with chemotherapy
por: Teng, Jia-wen, et al.
Publicado: (2013)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

Corrigendum: Decreased LKB1 predicts poor prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jian-Yu, et al.
Publicado: (2015)

The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

DNA–affibody nanoparticle delivery system for cisplatin-based breast cancer chemotherapy
por: Zhang, Chao, et al.
Publicado: (2019)

Relative roles of ABCG5/ABCG8 in liver and intestine
por: Wang, Jin, et al.
Publicado: (2015)

Functional Cooperativity between ABCG4 and ABCG1 Isoforms
por: Hegyi, Zoltán, et al.
Publicado: (2016)

ABCG5 and ABCG8 Are Involved in Vitamin K Transport
por: Matsuo, Michinori, et al.
Publicado: (2023)

Transcriptomic Insights into Functions of LkABCG36 and LkABCG40 in Nicotiana tabacum
por: Sun, Nan, et al.
Publicado: (2023)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

Polymorphisms in DNA repair pathway genes and ABCG2 gene in advanced colorectal cancer: correlation with tumor characteristics and clinical outcome in oxaliplatin-based chemotherapy
por: Hu, Xiaoyun, et al.
Publicado: (2018)

Trial on Refinement of Early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: The TREAT protocol
por: Kreuter, Michael, et al.
Publicado: (2007)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
por: Liu, Li-na, et al.
Publicado: (2013)

Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5 ABCG8
por: Williams, Kori, et al.
Publicado: (2021)

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
por: Xu, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aad5inbut13qj2aoq9odrtoihf